Changes in cell morphology consistent with disruption of membrane cytoskeletal protein distribution have previously been shown to occur with SL doses as low as 30 μg mL−1 in pancreatic H7402 and lung cancer A549 cell lines (Chen et al. 2006b). The gene discussed is SPTB; the disease is lung carcinoma.